Preliminary efficacy data from Phase 1/2 dose expansion cohort show durable responses and tumor shrinkage in a PD-(L)1 resistant “hot” tumor ...

Corporation is pleased to announce that with the support ofDRA Projects and other technical consultants, it has been ...

Ochsner Health Medical Director for Cardiac Rehabilitation and Preventive Cardiology, Carl J. "Chip" Lavie, Jr., MD, recently co-authored a groundbreaking research study featured in the prestigious ...

Texas football's group of 2025 NFL Draft hopefuls gathered at the Longhorns' training facility Tuesday to make one final ...